One in four people have some form of fatty liver disease, a condition that can be deadly but is often undiagnosed. 🤯

And what's more, this silent killer could be threatening more people by denying potential organ donation. While there's a critical shortage of transplantable livers, the fatty livers themselves cannot usually be used for transplant into others.

That might be about to change. Emma Keeling joins Oxford-based start-up Ochre Bio, which is using genomic medicines to switch off the fat-causing genes – so the livers can be donated.

🔬 Discover #RAZOR​​​​ Youtube Channel- The science show you need in your life: https://www.youtube.com/channel/UCvPxSZWJo7MVrWR7bLC45FQ

📲 Follow CGTN Europe on social media and other platforms👇https://stories.cgtneurope.tv/follow-cgtn-europe/index.html